GLUE
MONTE ROSA THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
MONTE ROSA THERAPEUTICS INC (GLUE) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$118.81M; the largest are Baker Bros. Advisors, Stanley Druckenmiller, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 2 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders41 also report options
Congress trades0
Price$11.74vs quarter-end-51.49%
Sectors0
This quarter's moves
Top holderBaker Bros. AdvisorsNew1
Added0
Trimmed / sold3
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $105.17M0.5% of portfolio4,345,7362026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $105.17M | 0.5% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $213.0K— of portfolio8,8002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $213.0K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.